Erudio Healtherudio.com
Sponsor
Calithera Biosciences trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Calithera Biosciences yet. Erudio has found public clinician commentary on 3 clinical trials sponsored by Calithera Biosciences: CANTATA, KEAPSAKE and NCT02071862. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Calithera Biosciences, Inc). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CANTATA NCT03428217 · Calithera Biosciences, Inc DeepView → | advanced or metastatic renal cell carcinoma | Phase 2 | Deep | View | |||
| NCT02071862 NCT02071862 · Calithera Biosciences, Inc FocusedView → | Not given | Phase 1 | Focused | View | |||
| KEAPSAKE NCT04265534 · Calithera Biosciences, Inc FocusedView → | first-line metastatic KEAP1/NRF2-mutated nonsquamous NSCLC | Phase 2 | Focused | View | |||